Back to Search Start Over

Immunobiologicals in dermatology

Authors :
Dimitri Luz Felipe da Silva
Elisa Nunes Secamilli
Mariana Valbon Beleli
Juliana Yumi Massuda
Andrea F.E.C. Franca
Renata F. Magalhães
Source :
Anais Brasileiros de Dermatologia, Vol 97, Iss 3, Pp 275-283 (2022)
Publication Year :
2022
Publisher :
Sociedade Brasileira de Dermatologia, 2022.

Abstract

Abstract Immunobiologicals are a reality in current clinical practice and have increasingly gained space in the inflammatory disease scenario, especially in dermatology, with approved drugs for psoriasis, atopic dermatitis, and hidradenitis suppurativa, in addition to many others undergoing study. It is important for dermatologists to have knowledge of the medications approved in Brazil, for the best management of dermatoses, in addition to the fact that they represent hope for improvement in patients with chronic diseases.

Details

Language :
English, Portuguese
ISSN :
03650596
Volume :
97
Issue :
3
Database :
Directory of Open Access Journals
Journal :
Anais Brasileiros de Dermatologia
Publication Type :
Academic Journal
Accession number :
edsdoj.88f3889c3f804e09a7382a94018a9979
Document Type :
article
Full Text :
https://doi.org/10.1016/j.abd.2021.05.016